Timing of Renal Replacement Therapy for Severe Acute Kidney Injury in Critically Ill Patients.


Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
01 05 2019
Historique:
pubmed: 21 2 2019
medline: 14 1 2020
entrez: 21 2 2019
Statut: ppublish

Résumé

Acute kidney injury (AKI) affects many ICU patients and is responsible for increased morbidity and mortality. Although lifesaving in many situations, renal replacement therapy (RRT) may be associated with complications, and the appropriate timing of its initiation is still the subject of intense debate. An early initiation strategy can prevent some metabolic complications, whereas a delayed one may allow for renal function recovery in some patients without need for this costly and potentially dangerous technique. For years, most of the knowledge on this issue stemmed from observational studies or small randomized controlled trials. Recent randomized controlled trials have indicated that a watchful waiting strategy (in the absence of life-threatening conditions such as severe hyperkalemia or pulmonary edema) during severe AKI allowed many patients to escape RRT and did not seem to adversely affect survival compared with a strategy of immediate RRT. In addition, data suggest that a delayed strategy may reduce the rate of complications (such as catheter infection) and favor renal function recovery. Ongoing studies will have to both confirm these conclusions and clarify to what extent the delay in initiating RRT can be prolonged. Pending those results, the bulk of evidence suggests that, in the absence of potential severe complications of AKI, delaying RRT is a valid and safe strategy that may also allow for considerable cost savings.

Identifiants

pubmed: 30785784
doi: 10.1164/rccm.201810-1906CP
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1066-1075

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Stéphane Gaudry (S)

1 AP-HP, Hôpital Avicenne, Service de Réanimation Médico-Chirurgicale, Bobigny, France.
2 INSERM UMR S 1155 "Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine," and.
3 Health Care Simulation Center, UFR SMBH, Université Paris 13, Sorbonne Paris Cité, Bobigny, France.

Jean-Pierre Quenot (JP)

4 Department of Intensive Care, François Mitterrand University Hospital, Dijon, France.
5 Lipness Team, INSERM Research Center, LNC-UMR1231 and LabEx LipSTIC, and.
6 INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.

Alexandre Hertig (A)

2 INSERM UMR S 1155 "Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine," and.
7 Renal ICU and Transplantation, Sorbonne Universités, Hôpital Tenon, AP-HP, Paris, France.

Saber Davide Barbar (SD)

8 Unité de Réanimation Médicale, CHU de Nîmes - Hôpital Carémeau, Nîmes, France.

David Hajage (D)

9 Département Biostatistique Santé Publique et Information Médicale, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, CIC-1421, AP-HP, Hôpital Pitié Salpêtrière, Paris, France.
10 INSERM, UMR 1123, ECEVE, Paris, France.

Jean-Damien Ricard (JD)

11 AP-HP, Hôpital Louis Mourier, Service de Réanimation Médico-Chirurgicale, Colombes, France.
12 IAME, UMRS 1137, University Paris Diderot, Sorbonne Paris Cité, Paris, France.
13 INSERM, IAME, U1137, Paris, France; and.

Didier Dreyfuss (D)

2 INSERM UMR S 1155 "Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine," and.
11 AP-HP, Hôpital Louis Mourier, Service de Réanimation Médico-Chirurgicale, Colombes, France.
14 University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH